New drug pricing policy raises concerns

The government’s plan to implement its revised volume forecast plan for a drug starting next year has triggered concerns from the domestic pharmaceutical community.

Under the plan, drug manufacturers and the National Health Insurance Corp. will be called to discuss the volume forecasts for a drug when it is first added to the reimbursement list. After one year, stakeholders are to reconvene...